![](https://news.unchealthcare.org/wp-content/uploads/sites/1159/2021/03/unc-research-logo.png)
March 30, 2021
Launch of New UNC Initiative- Advance Therapeutics (AdvanTX)
AdvanTX is a new initiative offering centralized resource support for development of therapeutic related research projects.
March 30, 2021
AdvanTX is a new initiative offering centralized resource support for development of therapeutic related research projects.
March 29, 2021
Research from the UNC School of Medicine lab of Jenny Ting, PhD, shows that the widely used drug metformin reduces metabolism of infected T cells to suppress HIV replication.
March 24, 2021
A pilot study from researchers at NC State and UNC school of Medicine shows evidence of Bartonella infection in the blood of people with schizophrenia and schizoaffective disorder. Flavio Frohlich, PhD, is the UNC School of Medicine lead.
March 24, 2021
Participate in 5-minute Survey on Side Effects of COVID-19 Vaccination for a Chance to Win a $50 Amazon Gift Card.
March 19, 2021
The article explores the clinical epidemiology and basic/translational issues of COVID-19 in patients with liver disease.
March 18, 2021
Researchers in the UNC School of Medicine Lab of Thomas Kash, PhD, published new findings in the journal Neuron showing how neurons in two brain regions use dopamine to promote pain responses differently in male and female mice.
March 17, 2021
Hear the stories from four different women who explain the importance of Black participants helping to reach medical advances.
March 17, 2021
Please review a list of competitive grants awarded to UNC School of Medicine faculty.
March 11, 2021
A study led by Muneera Kapadia, MD, associate professor of surgery in the UNC School of Medicine, is the first to examine the effect of a surgeon’s mask on communication with patients in the clinic setting. Results suggest that not seeing the surgeon’s face may have negative consequences on the surgeon-patient relationship.
March 10, 2021
In search of factors that increase vulnerability to the novel coronavirus, UNC Children’s Hospital providers, Tracie Walker, MD, and Stephanie Schwartz, MD, capture real-time data on children and youth hospitalized with COVID-19.
March 8, 2021
The findings reported on a secondary objective to reduce time to negative test result of infectious SARS-CoV-2 virus in individuals with symptomatic COVID-19. UNC School of Medicine’s William Fischer, MD, is the lead investigator on the study of Molnupiravir, the investigational drug also known as EIDD-2801.
March 4, 2021
The discovery, from the UNC School of Medicine lab of Mark Zylka, PhD, offers pain researchers a new, precise target to treat inflammation associated with neuropathic pain.